Receptor binding leads to the activation of NIK, which phosphorylates and activates an IKK alpha complex that in turn phosphorylates the IkB domain of p100 leading to the liberation of p52/RelB. This heterodimer subsequently translocates to the nucleus to activate target genes regulated by kB sites.